Welcome to our dedicated page for Celanese Del SEC filings (Ticker: CE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Celanese Corporation (NYSE: CE) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures, including Form 8-K current reports and other documents filed with the U.S. Securities and Exchange Commission. Celanese is a global specialty materials and chemical company in the basic organic chemical manufacturing industry, and its filings offer detailed insight into its financing activities, governance developments and operational decisions.
Recent Form 8-K filings describe a range of material events. Several filings outline registered offerings of senior notes by Celanese US Holdings LLC, a wholly owned subsidiary, including 7.000% Senior Notes due 2031 and 7.375% Senior Notes due 2034. These filings explain that net proceeds are used to repay borrowings under a five-year term loan credit agreement due 2027, fund cash tender offers for outstanding senior notes due 2027 and 2028, and support general corporate purposes, which may include repayment of other indebtedness.
Other 8-K reports cover cash tender offers for the company’s 6.665% Senior Notes due 2027 and 6.850% Senior Notes due 2028, including announcements of the commencement of tender offers, early results and increases in the maximum tender amount and series cap. Additional filings detail a revolving credit agreement providing a five-year unsecured revolving credit facility and an amendment to an existing term loan credit agreement, including new covenant terms.
Celanese filings also document operational and portfolio actions, such as the intended closure of an acetate tow production facility in Lanaken, Belgium, with associated expected non-cash accelerated depreciation and other shutdown costs, and the signing of a purchase and sale agreement to divest the Micromax® portfolio of products. Governance-related filings include the resignation of a Board member and the company’s explanation that the departure was not due to any disagreement on operations, policies or practices.
On Stock Titan, these SEC filings are presented with real-time updates from EDGAR and AI-powered summaries that help explain the key points of each document. Users can quickly understand the implications of Celanese’s 8-K disclosures, senior note offerings, credit agreements, tender offers and other reported events without reading every technical detail.
Celanese Corporation entered into a five-year unsecured Revolving Credit Agreement providing a $1.75 billion facility with a $250 million sublimit for letters of credit, replacing its prior revolver. The facility is available in U.S. dollars and certain other currencies and is guaranteed by the company, Celanese US Holdings LLC and certain domestic subsidiaries.
Borrowings accrue interest based on Daily Simple SOFR, Term SOFR or a customary base rate plus a margin of 1.00%–2.00% (or 0.00%–1.00% for U.S. dollar base rate borrowings), with undrawn amounts subject to a commitment fee of 0.09%–0.35%, each range tied to the company’s senior unsecured debt ratings. The agreement includes customary covenants—maintenance of a leverage ratio and a fixed charge coverage ratio—limits on dividends until a target ratio is met, and customary default provisions. Separately, Celanese US agreed to a Sixth Amendment to its Term Loan Credit Agreement adding a minimum consolidated fixed charge coverage ratio and similar dividend limitations. Full terms are in Exhibits 10.1 and 10.2.
Celanese reported mixed second-quarter results. Net sales declined to $2,532 million from $2,651 million a year earlier, and six-month sales fell to $4,921 million from $5,262 million. Despite lower sales, net earnings attributable to Celanese were $199 million for the quarter versus $155 million in Q2 2024, with diluted EPS of $1.81 versus $1.41.
Cash and liquidity improved: cash and cash equivalents rose to $1,173 million and operating cash flow for the six months was $447 million. Long-term debt increased to $12,689 million (net of current installments) driven by new debt issuances in 2025, including the 2025 Offering. The Company completed tender offers to retire near-term notes and announced intent to divest the Micromax portfolio. Significant foreign currency translation losses and other comprehensive loss reduced AOCI to $(903) million, and accumulated goodwill impairment in Engineered Materials remains $1.5 billion.
Celanese Corporation announced that its President and CEO, Scott A. Richardson, will present the company’s second quarter 2025 financial results in a webcast on August 12, 2025 at 9:00 a.m. ET. The company says the webcast, a press release, management's prepared remarks and a slide presentation will be available on the Celanese investor website under News & Events/Events Calendar.
The filing furnishes the prepared remarks and slide deck as Exhibit 99.1(a) and Exhibit 99.1(b), and provides a Non-US GAAP Financial Measures and Supplemental Information document as Exhibit 99.2 that defines and reconciles the non-GAAP measures referenced by management. The company notes these materials are being furnished, not filed, and therefore are not subject to Section 18 liabilities or incorporation by reference.
Celanese Corporation filed a Current Report on Form 8-K stating that on
The disclosure is provided pursuant to Item 2.02 (results of operations) and Item 9.01 (furnished exhibits). The filing states that the information and exhibits will not be incorporated by reference into other filings under the Securities Act or the Exchange Act.